Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Yip et al
Eli Lilly is targeting an FDA submission for retatrutide in late 2026, after the largest of its Phase 3 trials are published
Hims runs injectable compounded semaglutide around $175/month all-in and added a branded-oral Wegovy option through a 2026 Novo Nordisk partnership
Research context: For evidence on mechanisms, human and preclinical research, limitations, and safety, read AOD-9604 Peptide: Benefits, Uses, Side Effects, Dosage, and Research
GLP-1s through Ro start at $349 a month, with an additional charge for monthly program fees
US$ 22.09
US$ 26.87
US$ 28.94
US$ 25.31
